The home healthcare industry generates approximately $120 billion in annual revenue in the United States, delivering skilled nursing, therapy, aide services, and private duty care to millions of patients in their homes. The industry includes roughly 12,000 Medicare-certified home health agencies and thousands of additional non-certified agencies providing private duty and personal care services. Home health is one of the most actively consolidated sectors in healthcare, with PE-backed platforms, hospital systems, and national agencies acquiring aggressively to build geographic coverage, referral density, and operational scale.

The primary valuation method for home health agencies is Seller's Discretionary Earnings, or SDE, for smaller agencies, transitioning to EBITDA for larger operations. SDE adds the owner's salary, personal benefits, and non-recurring costs back to net income. In home health, the owner's compensation structure often includes a clinical salary component (if the owner is a nurse or therapist providing patient care), an administrative salary, and profit distributions. Common add-backs include the owner's total compensation, health insurance, vehicle expenses, continuing education, and any compliance consulting fees that are discretionary. Home health agencies generally trade between 2.5x and 4.5x SDE, with the range driven primarily by Medicare certification status, survey history, payer mix, census stability, service line diversity, and referral source diversification. An agency at 2.5x SDE has recent condition-level survey findings, heavy Medicare dependence, limited service lines, concentrated referral sources, and the owner providing significant clinical care. An agency at 4.5x has a pristine survey history, diversified payer mix with meaningful commercial and private duty revenue, full-service clinical capabilities, diversified referral sources, and professional management running daily operations.

Revenue multiples for home health agencies typically fall between 0.4x and 0.8x, reflecting the moderate margin profile and reimbursement complexity of the industry. Net margins range from 8% to 18% depending on payer mix, clinical efficiency, and reimbursement management. Revenue multiples should be evaluated in the context of payer mix — Medicare revenue carries different margin characteristics than commercial or private duty revenue, and buyers value the streams differently.

For larger home health operations generating $1M or more in annual EBITDA, institutional buyers use EBITDA multiples in the 6x to 12x range — among the highest in healthcare services. These premium multiples reflect the industry's favorable demographic tailwinds (aging population), high barriers to entry (Medicare certification), and growing demand for home-based care as an alternative to institutional settings. PE-backed home health platforms, hospital systems building post-acute care networks, and national agencies evaluate geographic coverage, referral network quality, clinical outcomes, and regulatory standing.

The unique valuation factor in home health is the regulatory gatekeeping function of Medicare certification and survey compliance. In most industries, a buyer can replicate the business if they don't acquire it — they can open a competing location, hire similar staff, and build a customer base. In home health, the 12–24 month Medicare certification timeline, the regulatory complexity of survey compliance, and the established referral relationships required to build census create an acquisition premium that exists independent of financial performance. Buyers are often paying for the certification itself as much as for the agency's cash flow. This regulatory moat means that even modestly profitable home health agencies with clean certifications attract buyer interest, while highly profitable agencies with regulatory problems face severely limited buyer pools. The implication for owners is clear: regulatory compliance is not a cost center — it is the primary value driver. Every dollar invested in survey readiness, documentation quality, and compliance infrastructure directly protects and enhances the agency's sale price. Owners who view compliance as an operational burden rather than a value-creation activity consistently underperform in M&A outcomes. Investing in a compliance officer, conducting regular mock surveys, and maintaining documentation standards that exceed minimum requirements is the most effective pre-sale value strategy in home health.

The home healthcare M&A market is driven by demographic forces that make the sector increasingly attractive. PE-backed platforms have invested billions building national home health portfolios. Hospital systems acquire agencies to control post-acute care pathways and reduce readmission penalties. National agencies pursue geographic expansion and payer diversification. For agencies with clean Medicare certification, strong survey histories, diversified payers, and established referral networks, the market offers premium multiples and competitive bidding. Agencies with regulatory issues or certification risk face a dramatically narrower buyer pool and should prioritize compliance remediation before pursuing a sale.

Use our free calculator above to get your instant estimate, then track your value monthly with YourExitValue.